We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

23 hedge funds and large institutions have $54.2M invested in Urovant Sciences Ltd. in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 25 → 23 (-2)

13% less capital invested

Capital invested by funds: $62.4M → $54.2M (-$8.21M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$330K
2
PHS
Pekin Hardy Strauss
Illinois
+$329K
3
MWNA
Marshall Wace North America
New York
+$240K
4
VWM
Vigilare Wealth Management
Arizona
+$24.9K
5
CFGS
Concourse Financial Group Securities
Alabama
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.12M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.28M
3
BBVA
Banco Bilbao Vizcaya Argentaria
Spain
-$1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$460K
5
Millennium Management
Millennium Management
New York
-$340K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$22.1M – – –
BBA
2
Baker Bros. Advisors
New York
$9.14M -$191K -21,495 -2%
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$5.8M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.31M -$1.28M -144,300 -20%
PHS
5
Pekin Hardy Strauss
Illinois
$3.96M +$329K +37,083 +10%
SB
6
Samsara BioCapital
California
$1.47M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.23M – – –
WCM
8
Wildcat Capital Management
New York
$884K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$833K – – –
BlackRock
10
BlackRock
New York
$667K -$2.12M -238,720 -77%
Northern Trust
11
Northern Trust
Illinois
$548K -$3.29K -371 -0.6%
Renaissance Technologies
12
Renaissance Technologies
New York
$537K -$460K -51,828 -47%
KCM
13
Kornitzer Capital Management
Kansas
$477K – – –
MWNA
14
Marshall Wace North America
New York
$397K +$240K +27,001 +174%
LA
15
LVW Advisors
New York
$363K – – –
Wells Fargo
16
Wells Fargo
California
$352K +$330K +37,147 +6,742%
VWM
17
Vigilare Wealth Management
Arizona
$121K +$24.9K +2,800 +27%
CFGS
18
Concourse Financial Group Securities
Alabama
$12K +$11.1K +1,250 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$3K -$213 -24 -7%
BBVA
20
Banco Bilbao Vizcaya Argentaria
Spain
– -$1M -101,975 Closed
Millennium Management
21
Millennium Management
New York
– -$340K -34,578 Closed
First Trust Advisors
22
First Trust Advisors
Illinois
– -$151K -15,299 Closed
TRCT
23
Tower Research Capital (TRC)
New York
– -$6K -649 Closed
UBS Group
24
UBS Group
Switzerland
– -$3K -329 Closed
Bank of America
25
Bank of America
North Carolina
– -$44 -5 -13%
1
2

UROV Hedge Fund Activity: Q3 2020 in Review

23 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q3 2020, worth a combined $54.2M — down 13% from $62.4M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of UROV and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Wells Fargo, adding an estimated $330K. The largest seller was BlackRock, cutting an estimated $2.12M.

  • 23 institutional investors held Urovant Sciences Ltd. (UROV) as of Q3 2020, down from 25 in Q2 2020.
  • Funds reported $54.2M of Urovant Sciences Ltd. stock for Q3 2020, down 13% quarter-over-quarter.
  • 3 funds opened new Urovant Sciences Ltd. positions in Q3 2020 and 5 closed out, a net change of -2 holders.
  • The largest Urovant Sciences Ltd. buyer in Q3 2020 was Wells Fargo, an estimated $330K added.
  • The largest Urovant Sciences Ltd. seller in Q3 2020 was BlackRock, an estimated $2.12M sold.

Based on aggregated 13F filings for Q3 2020.